Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
<p>HIV-1 has claimed the lives of millions of people globally and continues to spread despite development of highly active antiretroviral therapy. In 2013, 2.1 million new infections occurred and over 35 million people were living with HIV-1 infection. A prophylactic HIV-1 vaccine that can pre...
主要な著者: | Ahmed, T, Tina Ahmed |
---|---|
その他の著者: | Hanke, T |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2014
|
主題: |
類似資料
-
The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
著者:: Wan, L, 等
出版事項: (2012) -
Architecture of the HIV-1 glycan shield
著者:: Pritchard, L
出版事項: (2014) -
HIV-specific interleukin-10 responses and immune modulation
著者:: Clutton, G
出版事項: (2012) -
Antibody-based HIV-1 vaccines: recent developments and future directions
著者:: Montefiori, D, 等
出版事項: (2007) -
T-cell receptor (TCR) usage in HIV-2 infection
著者:: Moysi, E
出版事項: (2012)